IRLAB Therapeutics and the McQuade Center for Strategic Research and Development Enter into Agreement to Evaluate IRLAB's Neuropsychiatric Programs IRL757 and IRL942
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGOTHENBURG, SWEDEN / ACCESSWIRE / May 16, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA); IRLAB Therapeutics
Source: finanznachrichten.de